Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation

por Domingo-Domènech, Eva, Sureda, Anna
Publicado 2020

Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy

por Velasco, Roser, Domingo-Domenech, Eva, Sureda, Anna
Publicado 2021

Probabilistic Risk Characterization of Heavy Metals in Peruvian Coffee: Implications of Variety, Region and Processing

por Guadalupe, Grobert A., Chavez, Segundo G., Arellanos, Erick, Doménech, Eva
Publicado 2023

Organizing pneumonia in a patient with hodgkin’s lymphoma and large B cell lymphoma: a rare association

por Bordas-Martinez, Jaume, Gasa, Mercè, Domingo-Domènech, Eva, Vicens-Zygmunt, Vanesa
Publicado 2020

Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives

por Prince, H. Miles, Hutchings, Martin, Domingo-Domenech, Eva, Eichenauer, Dennis A., Advani, Ranjana
Publicado 2022

PB2329: ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL): MULTICENTRIC REVIEW OF CLINICAL FEATURES AND TREATMENT: ON BEHALF OF GELTAMO (GRUPO ESPAÑOL DE LINFOMAS Y TRASPLANTES DE MÉDU...

por Infante, Maria Stefania, Garcia-Sancho, Alejandro Martin, Luzardo, Hugo, Gomez, Marta, Domènech, Eva Domingo
Publicado 2023

Comparison of different automatic methods for the delineation of the total metabolic tumor volume in I–II stage Hodgkin Lymphoma

por Martín-Saladich, Queralt, Reynés-Llompart, Gabriel, Sabaté-Llobera, Aida, Palomar-Muñoz, Azahara, Domingo-Domènech, Eva, Cortés-Romera, Montse
Publicado 2020

P1130: FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PH...

por Iyer, Swaminathan, Jagadeesh, Deepa, Domingo Domènech, Eva, Benedetti, Fabio, Rodriguez Izquierdo, Antonia, Bouabdallah, Kamal, Vitolo, Umberto, Illidge, Tim, Liu, Jingmin, Knowles, Scott, Horwitz, Steven
Publicado 2023

Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma

por Maluquer, Clara, Bellosillo, Beatriz, Mussetti, Alberto, Domingo‐Domènech, Eva, Parody, Rocío, Fernández‐Ibarrondo, Lierni, Velasco, Roser, Moreno‐González, Gabriel, Sanz, Gabriela, Cortés, Montserrat, Sureda, Anna
Publicado 2020

P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST-HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDY

por Kim, Won-Seog, Shortt, Jake, Luigi Zinzani, Pier, Mikhaylova, Natalya, Marin-Niebla, Ana, Radeski, Dejan, Ribrag, Vincent, Domingo Domènech, Eva, Sawas, Ahmed, Alexis, Karenza, Emig, Michael, Garcia, Linta, Overesch, Andre, Pietzko, Kerstin, Horwitz, Steven
Publicado 2023

IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma

por Pirosa, Maria Cristina, Sassone, Marianna, Kiesewetter, Barbara, Guillermo, Armando Lopez, Devizzi, Liliana, Domènech, Eva Domingo, Tucci, Alessandra, Mannina, Donato, Merli, Michele, Salar, Antonio, Visco, Carlo, Esposito, Fabiana, Bonomini, Luisella, Zucca, Emanuele, Ferreri, Andrés J. M., Raderer, Markus
Publicado 2022

Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies

por Farre, Lourdes, Sanz, Gabriela, Ruiz-Xivillé, Neus, Castro de Moura, Manuel, Martin-Tejera, Juan Francisco, Gonçalves-Ribeiro, Samuel, Martinez-Iniesta, Maria, Calaf, Monica, Luis Mosquera, Jose, Martín-Subero, José Ignacio, Granada, Isabel, Esteller, Manel, Domingo-Domenech, Eva, Climent, Fina, Villanueva, Alberto, Sureda, Anna
Publicado 2021

T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Tri...

por Gallamini, Andrea, Picardi, Marco, Filonenko, Kateryna, Gotti, Manuel, Céspedes, Javier Núñez, Rossi, Andrea, Domingo-Domènech, Eva, Giza, Agnieszka, Sorasio, Roberto, Trentin, Livio, Oteiro, Mariana Bastos, Paszkiewicz-Kozik, Ewa, Sanz, Ramon García, Patti, Caterina, Chauvie, Stephane, Bergesio, Fabrizio, Guerra, Luca, Rambaldi, Alessandro, Balari, Ana Sureda, Zaucha, Jan Maciej
Publicado 2022

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

por Condom, Maria, Mussetti, Alberto, Maluquer, Clara, Parody, Rocío, González‐Barca, Eva, Arnan, Montserrat, Albasanz‐Puig, Adaia, Pomares, Helena, Salas, Maria Queralt, Carro, Itziar, Peña, Marta, Clapes, Victòria, Baca Cano, Cristina, Oliveira Ramos, Ana Carla, Sanz‐Linares, Gabriela, Moreno‐González, Gabriel, Mercadal, Santiago, Boqué, Concepcion, Gudiol, Carlota, Domingo‐Domènech, Eva, Sureda, Anna
Publicado 2021

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment

por Bastos Oreiro, Mariana, Martín, Reyes, Gomez, Pilar, López Muñoz, Nieves, Rodriguez, Antonia, Liébana, Marta, Navarro, Belén, Sánchez-González, Blanca, Marí, Pilar, Pérez de Oteiza, Jaime, Gutiérrez, Antonio, Bento, Leyre, Domingo Doménech, Eva, Vidal, María Jesús, Del Campo, Raquel, Pérez Ceballos, Elena, Infante, María, Roldán, Alicia, García Belmonte, Daniel, Santero, Miriam, Sureda, Anna, Sanz, Ramón García
Publicado 2021

Role of stem cell transplant in CD30(+) PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

por Savage, Kerry J., Horwitz, Steven M., Advani, Ranjana, Christensen, Jacob Haaber, Domingo-Domenech, Eva, Rossi, Giuseppe, Morschhauser, Franck, Alpdogan, Onder, Suh, Cheolwon, Tobinai, Kensei, Shustov, Andrei, Trneny, Marek, Yuen, Sam, Zinzani, Pier Luigi, Trümper, Lorenz, Ilidge, Tim, O’Connor, Owen A., Pro, Barbara, Miao, Harry, Bunn, Veronica, Fenton, Keenan, Fanale, Michelle, Puhlmann, Markus, Iyer, Swaminathan
Publicado 2022

Unraveling the genetics of transformed splenic marginal zone lymphoma

por Grau, Marta, López, Cristina, Navarro, Alba, Frigola, Gerard, Nadeu, Ferran, Clot, Guillem, Bastidas-Mora, Gabriela, Alcoceba, Miguel, Baptista, Maria Joao, Blanes, Margarita, Colomer, Dolors, Costa, Dolors, Domingo-Domènech, Eva, Enjuanes, Anna, Escoda, Lourdes, Forcada, Pilar, Giné, Eva, Lopez-Guerra, Mónica, Ramón, Olga, Rivas-Delgado, Alfredo, Vicente Folch, Laura, Wotherspoon, Andrew, Climent, Fina, Campo, Elias, López-Guillermo, Armando, Matutes, Estella, Beà, Sílvia
Publicado 2023

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clin...

por Sureda-Balari, Anna, Terol, M. José, Domingo-Domènech, Eva, Rodriguez, Ana Pilar González, Mohedo, Francisca Hernández, Céspedes, Javier Núñez, De La Cruz Vicente, Fátima, Muñoz, Carmen Martínez, Díaz, M. Elena Amutio, Córdoba, Raul, Izquierdo, Antonia Rodríguez, Domínguez, Samuel Romero, Meijide, Javier Briones, Greil, Richard, Velázquez, Miriam Moreno, Rubio, Araceli, Oteiro, Mariana Bastos, Gómez, Pilar, Avivi, Irit, Casanova, María, Del Campo García, Raquel, Noriega, Victor, Blanco, José Javier Sánchez, Sanz, Ramón. García
Publicado 2022

Clinical and pathological characteristics of peripheral T‐cell lymphomas in a Spanish population: a retrospective study

por Rodriguez‐Pinilla, Socorro Maria, Domingo‐Domenech, Eva, Climent, Fina, Sanchez, Joaquin, Perez Seoane, Carlos, Lopez Jimenez, Javier, Garcia‐Cosio, Monica, Caballero, Dolores, Blanco Muñez, Oscar Javier, Carpio, Cecilia, Castellvi, Josep, Martinez Pozo, Antonio, Gonzalez Farre, Blanca, Bendaña, Angeles, Aliste, Carlos, Gonzalez, Ana Julia, Gonzalez de Villambrosia, Sonia, Piris, Miguel A., Gomez Codina, Jose, Mayordomo‐Aranda, Empar, Navarro, Belen, Bellas, Carmen, Rodriguez, Guillermo, Borrero, Juan Jose, Ruiz‐Zorrilla, Ana, Grande, Marta, Montoto, Carmen, Cordoba, Raul
Publicado 2020